Most people are carriers for at least one genetic condition, meaning that any individual might need the help of a genetic counsellor a few times throughout their lifetime.

Last month, UK-based Sano Genetics launched Light the Way, an online support platform offering genetic testing and counselling for people suffering from motor neurone disease (MND) or with a family history of the condition.

As the demand for genetic testing and counselling booms, new approaches such as AI are being utilised to address the shortage of genetic counsellors.

Digital genetics company Igentifys digital genetic assistant (DGA) uses AI to power genetic counselling. It develops personalised multimedia content to explain genetic test results and consent processes to patients digitally. The platform which integrates with labs and healthcare providers automates parts of the counselling workflow, from scheduling tests to automatically generating reports.

Co-founder and CEO Dr Doron Behar says Igentifys platform can address the growing demand for clinical genetic testing: The demand for clinical genetic testing is skyrocketing. In todays market, we have over 27 million annual clinical genetic tests that are being done globally. But for all of these, we have only 7000 genetic counsellors available worldwide.

Behar explained that many people would prefer an automated video instead of a face-to-face appointment, due to waiting lists, and healthcare providers having a limited time for each patient. This is supported by data from Igentifys expanded carrier screen (ECS) study (NCT04248504).

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Your download email will arrive shortly

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

Country * UK USA Afghanistan land Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Democratic Republic of the Congo Cook Islands Costa Rica Cte d"Ivoire Croatia Cuba Curaao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Runion Romania Russian Federation Rwanda Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and The Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and The South Sandwich Islands Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates US Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam British Virgin Islands US Virgin Islands Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Kosovo

Industry * Academia & Education Aerospace, Defense & Security Agriculture Asset Management Automotive Banking & Payments Chemicals Construction Consumer Foodservice Government, trade bodies and NGOs Health & Fitness Hospitals & Healthcare HR, Staffing & Recruitment Insurance Investment Banking Legal Services Management Consulting Marketing & Advertising Media & Publishing Medical Devices Mining Oil & Gas Packaging Pharmaceuticals Power & Utilities Private Equity Real Estate Retail Sport Technology Telecom Transportation & Logistics Travel, Tourism & Hospitality Venture Capital

Tick here to opt out of curated industry news, reports, and event updates from Medical Device Network.

Submit and download

The ECS study evaluated the DGA in 225 couples undergoing ECS via the Thermo Fisher Scientific CarrierScan. Results demonstrated that the system saved traditional face-to-face or telephonic counselling in 73% of couples who were not carriers of a mutation in the same gene. Out of these, only 5.4% requested face-to-face counselling. In addition, patient survey responses showed that 90% of patients preferred digital results.

The AI genetic consultancy raised $10.5m in a 2019 funding round led by life sciences venture fund aMoon and crowdfunding platform OurCrowd. Founded in 2016, Igentify has partnered with companies such as Illumina and Thermo Fisher Scientific for its DGA.

AI is expected to drive the next industrial revolution, according to a report on GlobalDatas Medical Intelligence Center. Analysts estimate the total AI market will be worth $1tn by 2030, up from $103bn in 2023.

You simply dont have enough personnel to explain about the booming of knowledge in medicine to follow up on patients and so forth. We are here to pioneer and be part of this revolution, concluded Behar.

Give your business an edge with our leading industry insights.

Originally posted here:
How Igentify are revolutionising genetic testing using AI - Medical Device Network

Comments are closed.